Journals / Türk Oftalmoloji Dergisi / 2019 / Cilt: 49 - Sayı: 4

Corneal Endothelial Morphology and Thickness Changes in Patients with Gout

Gut Hastalığı Olan Bireylerde Kornea Endotel ve Kalınlık Değişiklikleri

Pages
178–182
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Altered corneal endothelial function was found in patients with gout when compared to healthy subjects and the alteration increased as gout duration and uric acid value increased.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To investigate corneal endothelial cell density (ECD), morphology, and central corneal thickness (CCT) in patients with gout compared with healthy subjects.
📊
Key Findings & Data:Materials and Methods: Fifty eyes of 50 gout patients and 50 eyes of 50 healthy subjects without gout or any other systemic disease were included in this study.
💡
Conclusion & Impact:Conclusion: Altered corneal endothelial function was found in patients with gout when compared to healthy subjects and the alteration increased as gout duration and uric acid value increased.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To investigate corneal endothelial cell density (ECD), morphology, and central corneal thickness (CCT) in patients with gout compared with healthy subjects. Materials and Methods: Fifty eyes of 50 gout patients and 50 eyes of 50 healthy subjects without gout or any other systemic disease were included in this study. After detailed ophthalmologic examination, specular microscopy (Tomey EM-4000; Tomey Corp) measurement was performed for all participants. ECD, average cell area (ACA), coefficient of variation (CV), hexagonality ratio, and CCT values were recorded. Results: Mean ECD and hexagonality ratio were lower (p=0.004 and p=0.002) and CV, ACA, and CCT values were higher (p=0.001, p=0.007, and p=0.001) in patients with gout when compared to healthy subjects. There were significant correlations between gout disease duration and CD and hexagonality ratio (p=0.019 and p=0.043) and also between uric acid value and hexagonality ratio and CCT (p=0.044 and p=0.003). Conclusion: Altered corneal endothelial function was found in patients with gout when compared to healthy subjects and the alteration increased as gout duration and uric acid value increased.

Özet

Amaç: Gut hastalarında kornea endotel hücre yoğunluğu, morfolojisi ve merkezi kornea kalınlığını (MKK) araştırmak ve sağlıklıbireylerle karşılaştırmaktır.Gereç ve Yöntem: Gut hastalığı tanısı ile takip edilen 50 hastanın 50 gözü ve gut ya da herhangi bir sistemik hastalığı olmayan 50sağlıklı bireyin 50 gözü çalışmaya dahil edildi. Detaylı göz muayenesi sonrasında tüm bireylere speküler mikroskopi (Tomey EM-4000;Tomey Corp) ile ölçüm yapıldı. Endotel hücre yoğunluğu (EHY), ortalama hücre boyutu (OHB), hücre alanının varyasyon katsayısı(VK), hekzagonal hücrelerin yüzdesi (HHY) ve MKK değerleri not edildi.Bulgular: Gut grubunda kontrol grubu ile karşılaştırıldığında, ortalama EHY ve HHY değerleri daha düşük (p=0,004 ve p=0,002);VK, OHB ve MKK değerleri daha yüksek (p=0,001, p=0,007 ve p=0,001) bulundu. Gut hastalığı süresi ile EHY ve HHY arasında(p=0,019 ve p=0,043) ve ürik asit düzeyi ile HHY ve MKK arasında (p=0,044 ve p=0,003) anlamlı korelasyonlar saptandı.Sonuç: Kornea endotel fonksiyonu gut hastalarında sağlıklı bireylere kıyasla daha bozuk idi ve endotel fonksiyonundaki bozulmahastalık süresi ve kontrolsüz ürik asit düzeyi arttıkça artma eğiliminde idi.

🔖

Cite This Article

TEKİN, K., GÖKER, Y. Ş., ATILGAN, C. Ü., ATILGAN, K. G., KOÇ, M., ÇAĞLAYAN, M., KÖSEKAHYA, P. (2022). Corneal Endothelial Morphology and Thickness Changes in Patients with Gout. Türk Oftalmoloji Dergisi, Cilt: 49 - Sayı: 4, 178–182. https://ajindex.com/articles/637745

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388:2039-2052
  2. Gümüşdiş G, Doğanavşargil E. Gümüşdiş G. Kristallere bağlı artropatiler. Klinik Romatoloji
  3. Basım. İstanbul; 1999:489-496
  4. Cameron JS, Moro F, Simmonds HA. Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr Nephrol. 1993;7:105-118
  5. Bardin T, Bouée S, Clerson P, Chalés G, Flipo RM, Lioté F, Perez V, Poiraud T, Schaeverbeke T, Richette P. Prevalence of gout in the adult population of France. Arthritis Care Res. 2016;68:261-266
  6. Cakır N, Pamuk ÖN, Derviş E, Imeryüz N, Uslu H, Benian Ö, Elelçi E, Erdem G, Sarvan FO, Senocak M. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int. 2012;32:895-908
  7. Birlik M, Gurler O, Akar S, Sari I, Onen F, Akkoc N. The prevalence of gout in an urban area of Izmir, Turkey: a population-based epidemiological study. Int J Clin Pract. 2014;68:775-782
  8. Anton FM, Garcia Puig J, Ramos T, Gonzalez P, Ordas J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986;35:343-3488. Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010;6:30-38
  9. Singh JA. Gout: will the “King of Diseases” be the first rheumatic disease to be cured? BMC Med. 2016;14:180
  10. Lin J, Zhao GQ, Che CY, Yang SS, Wang Q, Li CG. Characteristics of ocular abnormalities in gout patients. Int J Ophthalmol. 2013;6:307-311. 11. 11.Bernad B, Narvaez J, Diaz-Torné C, Diez-Garcia M, Valverde J. Clinical image: corneal tophus deposition in gout. Arthritis Rheum. 2006;54:1025
  11. Sarma P, Das D, Deka P, Deka AC. Subconjunctival urate crystals: a case report. Cornea. 2010;29:830-832
  12. Srinivas SP. Dynamic regulation of barrier integrity of the corneal endothelium. Optom Vis Sci. 2010;87:239-254
  13. Kosekahya P, Atilgan KG, Atilgan CU, Tekin K, Koc M, Caglayan M, Ayli D, Yilmazbas P. Could corneal densitometry be used as a diagnostic and screening tool for ocular involvement in patients with gout? Int Ophthalmol. 2019;39:991-1001
  14. Tekin K, Sekeroglu MA, Kiziltoprak H, Yilmazbas P. Corneal densitometry in healthy corneas and its correlation with endothelial morphometry. Cornea. 2017;36:1336-1342
  15. Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F Saag K, Singh JA, Sund